Ken Fisher’s Vir Biotechnology VIR Stock Holding History

Ken Fisher’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-253	Closed	-$6.21K	–	1259
2023 Q2	$6.21K	Buy	+253	New	+$6.35K	﹤0.01%	1116

Other funds holding VIR

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ken Fisher's VIR Position: Q3 2023 in Review

Ken Fisher sold out of Vir Biotechnology (VIR) in Q3 2023, closing a stake of 253 shares — an estimated $6.21K sold.

Ken Fisher first reported a position in VIR in Q2 2023 and held it in 1 quarter. The position peaked at $6.21K in Q2 2023. 214 funds tracked by Wall St. Rank hold VIR as of Q3 2023.

Ken Fisher reported no remaining Vir Biotechnology position as of Q3 2023 after selling out during the quarter.
Ken Fisher sold 253 Vir Biotechnology shares in Q3 2023, an estimated $6.21K.
Ken Fisher first reported a position in Vir Biotechnology in Q2 2023 and held it in 1 quarter.
Ken Fisher's Vir Biotechnology position peaked at $6.21K in Q2 2023.
214 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2023.

Based on Fisher Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.